Biotech IPOs: Lessons on How a Company Manages to Succeed After Failure Posted on 04/02/2014 by forbes The following post was published on the Knowledge@Wharton website on January 22, 2014. The data is in, and there is no question that 2013 was the most active year for biotechnology initial public...